These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 572992)

  • 41. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study.
    Bonhomme N; Cador M; Stinus L; Le Moal M; Spampinato U
    Brain Res; 1995 Mar; 675(1-2):215-23. PubMed ID: 7796132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
    Miller RT; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of amphetamine action after interruption of ascending serotonergic pathways.
    Green TK; Harvey JA
    J Pharmacol Exp Ther; 1974 Jul; 190(1):109-17. PubMed ID: 4136228
    [No Abstract]   [Full Text] [Related]  

  • 44. Behavioural effects of d-amphetamine in young chicks treated with p-Cl-phenylalanine.
    Schrold J; Squires RF
    Psychopharmacologia; 1971; 20(1):85-90. PubMed ID: 4254751
    [No Abstract]   [Full Text] [Related]  

  • 45. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.
    Hollister AS; Breese GR; Kuhn CM; Cooper BR; Schanberg SM
    J Pharmacol Exp Ther; 1976 Jul; 198(1):12-22. PubMed ID: 132524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regional brain serotonin receptor changes in differentially housed mice: effects of amphetamine.
    Essman EJ; Valzelli L
    Pharmacol Res Commun; 1984 Apr; 16(4):401-8. PubMed ID: 6539475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The increased release of 3H-5-hydroxytryptamine by d-para-methoxyamphetamine and d-amphetamine in vivo.
    Tseng LF
    Proc West Pharmacol Soc; 1976; 19():136-41. PubMed ID: 1036622
    [No Abstract]   [Full Text] [Related]  

  • 50. Theanine-induced reduction of brain serotonin concentration in rats.
    Yokogoshi H; Mochizuki M; Saitoh K
    Biosci Biotechnol Biochem; 1998 Apr; 62(4):816-7. PubMed ID: 9614715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Stress and serotonin metabolism in various regions of rat's central nervous system].
    Ladisich W
    Arzneimittelforschung; 1974 Jul; 24(7):1025-7. PubMed ID: 4408113
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 53. The effects of a single dose and prolonged benzene administration on 5-hydroxytryptamine and 5-hydroxyindolacetic acid content in rat brain.
    Paradowski M; Heimburger M; Cohen Y; Andrzejewski S
    Xenobiotica; 1984 Oct; 14(10):781-4. PubMed ID: 6209865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of several models of stress and amphetamine on brain levels of amphetamine and certain monoamines.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):474-83. PubMed ID: 5403613
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of the oxime and the hydroxylamine derivatives of 4-chloroamphetamine as depletors of brain 5-hydroxyindoles.
    Fuller RW; Perry KW; Baker JC; Parli CJ; Lee N; Day WA; Molloy BB
    Biochem Pharmacol; 1974 Dec; 23(23):3267-72. PubMed ID: 4441415
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of histamine on serotonin metabolism in rat brain.
    Maslinksi C; Nowak JZ
    Adv Exp Med Biol; 1981; 133():265-75. PubMed ID: 6172016
    [No Abstract]   [Full Text] [Related]  

  • 57. Altered 5-hydroxyindole concentrations in brain regions of rats treated with chlorpromazine in infancy.
    Taub H; Peters DA
    Gen Pharmacol; 1978; 9(2):97-100. PubMed ID: 658654
    [No Abstract]   [Full Text] [Related]  

  • 58. Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats.
    Fuller RW; Snoddy HD; Mason NR; Owen JE
    Neuropharmacology; 1981 Feb; 20(2):155-62. PubMed ID: 6163105
    [No Abstract]   [Full Text] [Related]  

  • 59. Intensification of amphetamine-induced excitation by methysergide, a serotonergic receptor blocker.
    Blum K; Wallace JE; Meyer E; Schwertner HA
    Experientia; 1977 Feb; 33(2):213-5. PubMed ID: 844561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Social isolation in the young rat: neurochemical correlates of chronic amphetamine treatment.
    Morinan A
    Ir J Med Sci; 1978 Aug; 147 Suppl 1():53-6. PubMed ID: 689853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.